(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are CELYAD ONCOLOGY, ONWARD MEDICAL, and IMMOBEL.

Financial Asset	Price	Change	Updated (EST)
CELYAD ONCOLOGY (CYAD.BR)	0.75	25%	2023-09-15 12:06:25
ONWARD MEDICAL (ONWD.BR)	4.30	11.11%	2023-09-15 12:21:15
IMMOBEL (IMMO.BR)	32.65	7.05%	2023-09-15 12:20:27
LAVIDE HOLDING (LVIDE.AS)	0.22	6.86%	2023-09-15 12:03:12
HAVILA SHIPPING (HAVI.OL)	9.89	6.69%	2023-09-15 12:40:31
ATLANTIC SAPPHIRE (ASA.OL)	1.58	6.6%	2023-09-15 12:25:40
NAVAMEDIC (NAVA.OL)	38.30	6.39%	2023-09-15 12:41:34
PHARMING GROUP (PHARM.AS)	1.29	5.82%	2023-09-15 12:03:59
SATS (SATS.OL)	12.40	5.8%	2023-09-15 12:43:15
CTAC (CTAC.AS)	3.70	5.71%	2023-09-15 12:01:37

The three biggest losers today are AFFLUENT MEDICAL, BENEVOLENTAI, and MKB Nedsense.

Financial Asset	Price	Change	Updated (EST)
AFFLUENT MEDICAL (AFME.PA)	1.36	-22.29%	2023-09-15 12:45:58
BENEVOLENTAI (BAI.AS)	0.90	-10%	2023-09-15 12:00:59
MKB Nedsense (NEDSE.AS)	0.10	-6.31%	2023-09-15 12:03:20
AKER HORIZONS (AKH.OL)	4.42	-5.95%	2023-09-15 12:25:20
ENSURGE MICROPOWER (ENSU.OL)	0.12	-5.78%	2023-09-15 12:26:59
INTEROIL EXPL PROD (IOX.OL)	0.65	-5.52%	2023-09-15 12:40:46
ASM INTERNATIONAL (ASM.AS)	393.50	-5.27%	2023-09-15 12:00:39
BELYSSE GROUP (BELYS.BR)	0.81	-4.47%	2023-09-15 12:06:07
HEXAGON COMPOSITES (HEX.OL)	35.70	-4.44%	2023-09-15 12:40:33
THUNDERBIRD (TBIRD.AS)	0.09	-4.21%	2023-09-15 12:04:47

Winners today

1. CELYAD ONCOLOGY (CYAD.BR)

25% Price Change

Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. Its lead product candidates include CYAD-101, an allogeneic CAR-T candidate that is in Phase 1b clinical trial for the treatment of metastatic colorectal cancer; CYAD-211, a short hairpin RNA (shRNA)-based allogeneic CAR-T candidate, which is in Phase 1 clinical trial to treat relapsed / refractory multiple myeloma; and CYAD-02, an autologous CAR-T candidate that is in Phase 1 clinical trial for the treatment of relapsed or refractory acute myeloid leukemia and myelodysplastic syndromes. It has licensing agreement with Novartis International AG regarding the United States patents related to allogeneic CAR-T cells; and research and development collaboration, and license agreements with Horizon Discovery Group plc for the use of its shRNA reagents to reduce expression of one or more defined targets. The company was formerly known as Celyad SA and changed its name to Celyad Oncology SA in June 2020. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium.

BEL 20 ended the session with CELYAD ONCOLOGY rising 25% to €0.75 on Friday, after three consecutive sessions in a row of losses. BEL 20 rose 0.61% to €3,712.38, following the last session’s upward trend on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, CELYAD ONCOLOGY has a trailing twelve months EPS of €-1.48.

Volume

Today’s last reported volume for CELYAD ONCOLOGY is 187340 which is 430.97% above its average volume of 35282.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CELYAD ONCOLOGY’s stock is considered to be overbought (>=80).

Volatility

CELYAD ONCOLOGY’s last week, last month’s, and last quarter’s current intraday variation average was a negative 6.63%, a positive 0.50%, and a positive 4.47%.

CELYAD ONCOLOGY’s highest amplitude of average volatility was 7.41% (last week), 8.21% (last month), and 4.47% (last quarter).

More news about CELYAD ONCOLOGY.

2. ONWARD MEDICAL (ONWD.BR)

11.11% Price Change

Onward Medical N.V., a medical technology company, focuses on developing therapies for spinal cord injuries in the Netherlands and internationally. The company engages in developing ARC-EX, an external non-invasive platform that consists of a wearable stimulator and wireless programmer; and ARCIM, an implantable platform, which consists of an implantable pulse generator and lead that is placed near the spinal cord. It also engages in developing Up-LIFT Trial to evaluate the safety and effectiveness of non-invasive electrical spinal cord stimulation to treat upper extremity functional deficits with chronic tetraplegia. The company was founded in 2014 and is headquartered in Eindhoven, Netherlands.

BEL 20 ended the session with ONWARD MEDICAL jumping 11.11% to €4.30 on Friday, following the last session’s upward trend. BEL 20 rose 0.61% to €3,712.38, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, ONWARD MEDICAL has a trailing twelve months EPS of €-1.04.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -48.44%.

Volume

Today’s last reported volume for ONWARD MEDICAL is 10727 which is 114.62% above its average volume of 4998.

Volatility

ONWARD MEDICAL’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.21%, a negative 1.16%, and a positive 1.99%.

ONWARD MEDICAL’s highest amplitude of average volatility was 5.09% (last week), 2.01% (last month), and 1.99% (last quarter).

Yearly Top and Bottom Value

ONWARD MEDICAL’s stock is valued at €4.30 at 22:40 EST, way under its 52-week high of €8.23 and above its 52-week low of €4.01.

Revenue Growth

Year-on-year quarterly revenue growth grew by 45.8%, now sitting on 2.15M for the twelve trailing months.

More news about ONWARD MEDICAL.

3. IMMOBEL (IMMO.BR)

7.05% Price Change

Immobel SA engages in the real estate development business in Belgium, Luxemburg, France, Germany, Poland, and Spain. The company undertakes office, residential, and retail projects, as well as develops real estate projects for living, working, and recreational activities. It also provides project management and leasing services. The company was formerly known as Allfin NV and changed its name to Immobel SA in June 2016. The company was incorporated in 1863 and is headquartered in Brussels, Belgium.

BEL 20 ended the session with IMMOBEL jumping 7.05% to €32.65 on Friday while BEL 20 jumped 0.61% to €3,712.38.

Earnings Per Share

As for profitability, IMMOBEL has a trailing twelve months EPS of €1.07.

PE Ratio

IMMOBEL has a trailing twelve months price to earnings ratio of 30.51. Meaning, the purchaser of the share is investing €30.51 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.79%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 47.6%, now sitting on 236.31M for the twelve trailing months.

Moving Average

IMMOBEL’s worth is under its 50-day moving average of €33.96 and way under its 200-day moving average of €42.94.

Volume

Today’s last reported volume for IMMOBEL is 4448 which is 15.38% above its average volume of 3855.

More news about IMMOBEL.

4. LAVIDE HOLDING (LVIDE.AS)

6.86% Price Change

Lavide Holding N.V. does not have significant operations. Previously, it was engaged in the provision of integrated information technology solutions for medium to large-sized companies and organizations. The company was formerly known as Qurius N.V. and changed its name to Lavide Holding N.V. in July 2013. Lavide Holding N.V. was incorporated in 1998 and is based in Sluis, the Netherlands.

AEX-Index ended the session with LAVIDE HOLDING jumping 6.86% to €0.22 on Friday, after three consecutive sessions in a row of losses. AEX-Index dropped 0.4% to €741.51, following the last session’s upward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, LAVIDE HOLDING has a trailing twelve months EPS of €-0.04.

More news about LAVIDE HOLDING.

5. HAVILA SHIPPING (HAVI.OL)

6.69% Price Change

Havila Shipping ASA, together with its subsidiaries, engages in the shipping business. It manages and operates offshore service vessels primarily in Norway, the United Kingdom, Denmark, Belgium, the Netherlands, Iceland, Tunisia, the Marshall Islands, and the United States. The company operates a fleet of 17 vessels, including 2 anchor handling vessels, 11 platform supply vessels, 1 rescue recovery vessel, and 3 subsea vessels. Its anchor handling tug and supply vessels are used for moving rigs and putting out anchors, as well as for supply services; platform supply vessels are used to carry goods, water, drilling mud, chemicals, etc. to and from the offshore installations; subsea vessels are used for under water construction work, as well as for support for under water operations; and rescue recovery vessels are used to offer security services, such as oil spill preparedness, fire protection, rescue operation, and recovery at oil installations. The company was founded in 2003 and is headquartered in Fosnavåg, Norway. Havila Shipping ASA is a subsidiary of Havila Holding AS.

Oslo Børs Benchmark Index_GI ended the session with HAVILA SHIPPING jumping 6.69% to €9.89 on Friday while Oslo Børs Benchmark Index_GI jumped 0.29% to €1,300.98.

Earnings Per Share

As for profitability, HAVILA SHIPPING has a trailing twelve months EPS of kr-4.66.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -59.03%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 7.6%, now sitting on 710.34M for the twelve trailing months.

More news about HAVILA SHIPPING.

6. ATLANTIC SAPPHIRE (ASA.OL)

6.6% Price Change

Atlantic Sapphire ASA, together with its subsidiaries, engages in the land-based salmon farming business. It operates through two segments, Fish Farming (Denmark); and Fish Farming (US). The company is involved in the production and sale of salmon. It operates in the United States, Denmark, and internationally. The company was founded in 2010 and is headquartered in Vikebukt, Norway.

Oslo Børs Benchmark Index_GI ended the session with ATLANTIC SAPPHIRE rising 6.6% to €1.58 on Friday while Oslo Børs Benchmark Index_GI rose 0.29% to €1,300.98.

Earnings Per Share

As for profitability, ATLANTIC SAPPHIRE has a trailing twelve months EPS of kr-5.71.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.

Moving Average

ATLANTIC SAPPHIRE’s worth is way under its 50-day moving average of kr6.29 and way under its 200-day moving average of kr6.74.

Volatility

ATLANTIC SAPPHIRE’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.29%, a negative 2.62%, and a positive 3.75%.

ATLANTIC SAPPHIRE’s highest amplitude of average volatility was 4.78% (last week), 5.14% (last month), and 3.75% (last quarter).

More news about ATLANTIC SAPPHIRE.

7. NAVAMEDIC (NAVA.OL)

6.39% Price Change

Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with NAVAMEDIC rising 6.39% to €38.30 on Friday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI rose 0.29% to €1,300.98, following the last session’s upward trend on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.18.

PE Ratio

NAVAMEDIC has a trailing twelve months price to earnings ratio of 32.46. Meaning, the purchaser of the share is investing kr32.46 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.19%.

Yearly Top and Bottom Value

NAVAMEDIC’s stock is valued at kr38.30 at 22:40 EST, way below its 52-week high of kr43.60 and way above its 52-week low of kr29.20.

Sales Growth

NAVAMEDIC’s sales growth is 22.8% for the ongoing quarter and 17.3% for the next.

More news about NAVAMEDIC.

8. PHARMING GROUP (PHARM.AS)

5.82% Price Change

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's commercialized product is RUCONEST, a plasma-free rhC1INH protein replacement therapy for the treatment acute hereditary angioedema (HAE) attacks. It also engages in the development of leniolisib for the treatment of activated phosphoinositide 3-kinase delta syndrome; OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE; and alpha-glucosidase therapy for the treatment of Pompe and fabry diseases. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. is headquartered in Leiden, the Netherlands.

AEX-Index ended the session with PHARMING GROUP jumping 5.82% to €1.29 on Friday, after five sequential sessions in a row of gains. AEX-Index dropped 0.4% to €741.51, following the last session’s upward trend on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, PHARMING GROUP has a trailing twelve months EPS of €-0.02.

More news about PHARMING GROUP.

9. SATS (SATS.OL)

5.8% Price Change

Sats ASA provides fitness and training services in Norway, Sweden, Denmark, and Finland. The company offers sportswear, fitness gear, bars, and energy drinks. It operates 275 fitness clubs under the SATS, ELIXIA, Fresh Fitness, SATSonline and SATSYoga brands. The company was founded in 1995 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with SATS rising 5.8% to €12.40 on Friday while Oslo Børs Benchmark Index_GI rose 0.29% to €1,300.98.

Earnings Per Share

As for profitability, SATS has a trailing twelve months EPS of kr-0.25.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.46%.

More news about SATS.

10. CTAC (CTAC.AS)

5.71% Price Change

Ctac N.V. provides business and cloud integration services primarily in the Netherlands and Belgium. The company offers cloud, programme and change management, agile consultancy, application management, license management, service desk and coordination management, implementation, and consultancy and advice services. It also provides various solutions for cloud infrastructure, SAP S/4HANA, workplace, cyber security, unified commerce, integration, data management, data and analytics, customer experience, and innovation. In addition, the company offers SAP data warehouse, security assessment, fiori, s/4 move and hana, ECC, business warehouse, analytics, and EVM; data sync manager, ometa, binder dam, winshuttle, winshuttle evolve, inriver pim, ETIM extension for inriver pim, mendix, and XV Retail; Fit4 Real Estate, omni customer loyalty, private cloud, pricing and promotion engine, and floating basket; and Microsoft azure public cloud, teams, route365 cooker session, sharepoint, and 365. It primarily serves retail, wholesale, manufacturing, real estate, and cross industries. The company was founded in 1992 and is headquartered in ‘s-Hertogenbosch, the Netherlands.

AEX-Index ended the session with CTAC jumping 5.71% to €3.70 on Friday while AEX-Index slid 0.4% to €741.51.

Earnings Per Share

As for profitability, CTAC has a trailing twelve months EPS of €0.29.

PE Ratio

CTAC has a trailing twelve months price to earnings ratio of 12.76. Meaning, the purchaser of the share is investing €12.76 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.36%.

More news about CTAC.

Losers Today

1. AFFLUENT MEDICAL (AFME.PA)

-22.29% Price Change

Affluent Medical SA develops minimally invasive medical devices for the treatment of heart and vascular diseases in France. It develops Kardiozis technology for the treatment of abdominal aortic aneurysm; Kalios and Epygon implants to treat mitral insufficiency; and Artus implant, an implantable electro-mechanical artificial sphincter for the treatment of severe urinary incontinence in women and men. The company was founded in 2011 and is based in Aix-en-Provence, France.

CAC 40 ended the session with AFFLUENT MEDICAL dropping 22.29% to €1.36 on Friday while CAC 40 jumped 0.96% to €7,378.82.

Earnings Per Share

As for profitability, AFFLUENT MEDICAL has a trailing twelve months EPS of €-1.35.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -39.36%.

Volatility

AFFLUENT MEDICAL’s last week, last month’s, and last quarter’s current intraday variation average was 22.14%, 3.27%, and 2.69%.

AFFLUENT MEDICAL’s highest amplitude of average volatility was 22.14% (last week), 4.63% (last month), and 2.69% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth declined by 25.8%, now sitting on 1.34M for the twelve trailing months.

Moving Average

AFFLUENT MEDICAL’s value is way above its 50-day moving average of €1.23 and under its 200-day moving average of €1.48.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AFFLUENT MEDICAL’s stock is considered to be oversold (<=20).

More news about AFFLUENT MEDICAL.

2. BENEVOLENTAI (BAI.AS)

-10% Price Change

BenevolentAI S.A. operates as a clinical-stage AI-enabled drug discovery and development company. Its BenevolentAI platform powers in-house drug pipeline of drug programs. The company's therapeutic areas, include atopic dermatitis, ulcerative colitis, amyotrophic lateral sclerosis, glioblastoma multiforme, inflammatory bowel disease, antiviral, oncology, parkinson's disease, nonalcoholic steatohepatitis, fibrosis, inflammation, chronic kidney disease, and idiopathic pulmonary fibrosis. It has a collaboration with AstraZeneca to enhance understanding of complex disease biology and identify new targets. The company was founded in 2013 and is headquartered in London, United Kingdom.

AEX-Index ended the session with BENEVOLENTAI dropping 10% to €0.90 on Friday, after two successive sessions in a row of losses. AEX-Index dropped 0.4% to €741.51, following the last session’s upward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, BENEVOLENTAI has a trailing twelve months EPS of €-1.75.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -152.53%.

More news about BENEVOLENTAI.

3. MKB Nedsense (NEDSE.AS)

-6.31% Price Change

MKB Nedsense N.V. engages in the finance and lending of money to natural persons and legal entities. It also provides guarantees and/or other securities towards third parties for its obligations and/or for obligations for companies in the investment portfolio. The company was formerly known as Nedsense Enterprises N.V. MKB Nedsense N.V. was founded in 1999 and is based in Bussum, the Netherlands.

AEX-Index ended the session with MKB Nedsense dropping 6.31% to €0.10 on Friday, following the last session’s upward trend. AEX-Index dropped 0.4% to €741.51, following the last session’s upward trend on what was a somewhat bearish trend trading session today.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.03%.

More news about MKB Nedsense.

4. AKER HORIZONS (AKH.OL)

-5.95% Price Change

Aker Horizons ASA, through its subsidiaries, develops and invests in a portfolio of companies in the renewable energy and green technology comprising private and public companies worldwide. It sources, develops, structures, builds, and operates wind and solar power assets; and develops, builds, owns, and operates clean hydrogen production at industrial scale. The company also provides products, technology, and solutions within the field of carbon capture, utilization, and storage. In addition, it offers products and services to the hydropower industry; designs and delivers superconducting systems; and produces silicon materials. The company was incorporated in 2020 and is headquartered in Lysaker, Norway. Aker Horizons ASA is a subsidiary of Aker Capital AS.

Oslo Børs Benchmark Index_GI ended the session with AKER HORIZONS falling 5.95% to €4.42 on Friday while Oslo Børs Benchmark Index_GI rose 0.29% to €1,300.98.

Earnings Per Share

As for profitability, AKER HORIZONS has a trailing twelve months EPS of kr-10.13.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -81.14%.

Yearly Top and Bottom Value

AKER HORIZONS’s stock is valued at kr4.42 at 22:40 EST, way under its 52-week low of kr5.12.

Moving Average

AKER HORIZONS’s worth is way under its 50-day moving average of kr6.41 and way below its 200-day moving average of kr10.38.

Revenue Growth

Year-on-year quarterly revenue growth grew by 60.8%, now sitting on 3B for the twelve trailing months.

Volatility

AKER HORIZONS’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.19%, a negative 0.72%, and a positive 2.92%.

AKER HORIZONS’s highest amplitude of average volatility was 2.79% (last week), 3.10% (last month), and 2.92% (last quarter).

More news about AKER HORIZONS.

5. ENSURGE MICROPOWER (ENSU.OL)

-5.78% Price Change

Ensurge Micropower ASA manufactures and sells ultrathin energy storage solutions for wearable devices, connected sensors, and other applications. Its solid-state lithium battery technology enables it to produce rechargeable batteries. The company was formerly known as Thin Film Electronics ASA and changed its name to Ensurge Micropower ASA in June 2021. Ensurge Micropower ASA was incorporated in 2005 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ENSURGE MICROPOWER sliding 5.78% to €0.12 on Friday, after four successive sessions in a row of gains. Oslo Børs Benchmark Index_GI rose 0.29% to €1,300.98, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, ENSURGE MICROPOWER has a trailing twelve months EPS of kr-0.76.

Volatility

ENSURGE MICROPOWER’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.59%, a negative 0.07%, and a positive 4.31%.

ENSURGE MICROPOWER’s highest amplitude of average volatility was 1.59% (last week), 2.44% (last month), and 4.31% (last quarter).

Earnings Before Interest, Taxes, Depreciation, and Amortization

ENSURGE MICROPOWER’s EBITDA is -150.46.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ENSURGE MICROPOWER’s stock is considered to be oversold (<=20).

Volume

Today’s last reported volume for ENSURGE MICROPOWER is 29489900 which is 124.29% above its average volume of 13147900.

More news about ENSURGE MICROPOWER.

6. INTEROIL EXPL PROD (IOX.OL)

-5.52% Price Change

Interoil Exploration and Production ASA, together with its subsidiaries, operates as an upstream oil exploration and production company. It engages in the acquisition, exploration, development, and operation of oil and natural gas properties. The company's portfolio includes two producing concessions and two exploration concessions in Colombia; and one exploration and seven production concessions in Argentina. Interoil Exploration and Production ASA was incorporated in 2005 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with INTEROIL EXPL PROD dropping 5.52% to €0.65 on Friday while Oslo Børs Benchmark Index_GI jumped 0.29% to €1,300.98.

Earnings Per Share

As for profitability, INTEROIL EXPL PROD has a trailing twelve months EPS of kr-0.34.

More news about INTEROIL EXPL PROD.

7. ASM INTERNATIONAL (ASM.AS)

-5.27% Price Change

ASM International NV, together with its subsidiaries, engages in the research, development, manufacture, marketing, and servicing of equipment and materials used to produce semiconductor devices in the United States, Europe, and Asia. Its products include wafer processing deposition systems for single-wafer atomic layer deposition, plasma enhanced chemical vapor deposition, epitaxy, silicon carbide, vertical furnace systems, and low pressure chemical vapor deposition and diffusion products, as well as provides spare parts and support services. The company also manufactures and sells equipment, which is used in wafer processing, encompassing the fabrication steps in which silicon wafers are layered with semiconductor devices. It offers its products to semiconductor manufacturers. The company was formerly known as Advanced Semiconductor Materials International NV. ASM International NV was incorporated in 1968 and is headquartered in Almere, the Netherlands.

AEX-Index ended the session with ASM INTERNATIONAL falling 5.27% to €393.50 on Friday, following the last session’s upward trend. AEX-Index fell 0.4% to €741.51, following the last session’s upward trend on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, ASM INTERNATIONAL has a trailing twelve months EPS of €12.45.

PE Ratio

ASM INTERNATIONAL has a trailing twelve months price to earnings ratio of 31.61. Meaning, the purchaser of the share is investing €31.61 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.13%.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on May 17, 2023, the estimated forward annual dividend rate is 2.5 and the estimated forward annual dividend yield is 0.57%.

Moving Average

ASM INTERNATIONAL’s value is below its 50-day moving average of €421.04 and way above its 200-day moving average of €350.11.

Earnings Before Interest, Taxes, Depreciation, and Amortization

ASM INTERNATIONAL’s EBITDA is 7.66.

Sales Growth

ASM INTERNATIONAL’s sales growth is 0.6% for the present quarter and negative 11.4% for the next.

More news about ASM INTERNATIONAL.

8. BELYSSE GROUP (BELYS.BR)

-4.47% Price Change

Belysse Group NV produces and sells textile floor coverings for commercial and residential applications in Europe, North America, and internationally. The company designs, manufactures, and distributes broadloom carpets and modular carpet tiles primarily for offices and public projects. It commercializes its products under the Bentley, modulyss, arc edition, and ITC brands. The company was formerly known as Balta Group NV and changed its name to Belysse Group NV in October 2022. Belysse Group NV was founded in 1964 and is headquartered in Waregem, Belgium. Belysse Group NV is a subsidiary of LSF9 Belysse Holdco S.à r.l.

BEL 20 ended the session with BELYSSE GROUP falling 4.47% to €0.81 on Friday, after two successive sessions in a row of gains. BEL 20 rose 0.61% to €3,712.38, following the last session’s upward trend on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, BELYSSE GROUP has a trailing twelve months EPS of €-0.48.

Volatility

BELYSSE GROUP’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.05%, a negative 0.93%, and a positive 3.51%.

BELYSSE GROUP’s highest amplitude of average volatility was 4.75% (last week), 3.24% (last month), and 3.51% (last quarter).

Volume

Today’s last reported volume for BELYSSE GROUP is 5525 which is 0.95% below its average volume of 5578.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BELYSSE GROUP’s stock is considered to be oversold (<=20).

More news about BELYSSE GROUP.

9. HEXAGON COMPOSITES (HEX.OL)

-4.44% Price Change

Hexagon Composites ASA, together with its subsidiaries, engages in the production and sale of composite pressure cylinders and fuel systems in Norway, Europe, North America, South-East Asia, the Middle East, and internationally. The company operates through four segments: Hexagon Agility, Hexagon Ragasco, Hexagon Digital Wave, and Hexagon Purus. The Hexagon Agility segment provides clean fuel solutions for commercial vehicles, passenger vehicles, and gaseous energy transportation. The Hexagon Ragasco segment manufacturers composite liquefied petroleum gas (LPG) cylinders for leisure, household, and industrial applications. The Hexagon Digital Wave segment offers cylinder testing and monitoring technology solutions that reduce down-time and inspection costs while improving inspection accuracy. Hexagon Purus segment provides high pressure cylinders, vehicle systems, and battery backs for fuel cell and battery electric vehicles that enable the safe and effective use of hydrogen and electricity as transportation fuel in various applications, including buses, distribution, refueling, rail, maritime, aerospace, and ground storage, as well as light, medium, and heavy-duty vehicles. Hexagon Composites ASA was incorporated in 1995 and is headquartered in Ålesund, Norway.

Oslo Børs Benchmark Index_GI ended the session with HEXAGON COMPOSITES sliding 4.44% to €35.70 on Friday while Oslo Børs Benchmark Index_GI rose 0.29% to €1,300.98.

Earnings Per Share

As for profitability, HEXAGON COMPOSITES has a trailing twelve months EPS of kr-1.53.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -10.41%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

HEXAGON COMPOSITES’s EBITDA is 1.79.

Sales Growth

HEXAGON COMPOSITES’s sales growth for the next quarter is negative 2.6%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 20% and 75.9%, respectively.

Volatility

HEXAGON COMPOSITES’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.17%, a positive 1.40%, and a positive 3.35%.

HEXAGON COMPOSITES’s highest amplitude of average volatility was 2.15% (last week), 2.73% (last month), and 3.35% (last quarter).

More news about HEXAGON COMPOSITES.

10. THUNDERBIRD (TBIRD.AS)

-4.21% Price Change

Thunderbird Resorts, Inc., through its subsidiaries, engages in the gaming, hospitality, and real estate businesses in Nicaragua and Peru. It provides table and slot games, and sportsbooks. The company operates 3 slot parlors, 3 casinos, and 630 gaming positions. It develops, owns, and operates real estate properties; and rents office spaces. The company was formerly known as International Thunderbird Gaming Corporation and changed its name to Thunderbird Resorts, Inc. in July 2005. Thunderbird Resorts, Inc. was incorporated in 1987 and is headquartered in Panama, the Republic of Panama.

AEX-Index ended the session with THUNDERBIRD sliding 4.21% to €0.09 on Friday while AEX-Index dropped 0.4% to €741.51.

Earnings Per Share

As for profitability, THUNDERBIRD has a trailing twelve months EPS of €0.01.

PE Ratio

THUNDERBIRD has a trailing twelve months price to earnings ratio of 9.1. Meaning, the purchaser of the share is investing €9.1 for every euro of annual earnings.

Volatility

THUNDERBIRD’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.08%, a negative 0.36%, and a positive 4.24%.

THUNDERBIRD’s highest amplitude of average volatility was 4.79% (last week), 2.91% (last month), and 4.24% (last quarter).

Volume

Today’s last reported volume for THUNDERBIRD is 1000 which is 98.24% below its average volume of 56961.

More news about THUNDERBIRD.

Stay up to date with our winners and losers daily report